jVen Capital

Venture Capital Potomac, Maryland, United States ·Founded 2007

Overview

jVen Capital is a Maryland-based venture capital firm specialized in growth equity investments.

Investment Focus

  • Focus on personalized medicine, genetics, and medical devices
  • Active management and strategic direction
  • Commitment to building sustainable, market-leading businesses

Portfolio Companies

Foundation MedicineVeracyteSunwinkGeneWerk Holdings GmbHKyverna TherapeuticsFluidigmAssurex HealthCAS Medical SystemssuperDimensionDigene CorpSignature Genomic LaboratoriesOpGen

Get the full list of 54,000+ investors

jVen Capital and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about jVen Capital

What sectors does jVen Capital invest in?

jVen Capital invests in Healthcare, Digital Health, Medical Devices, Personalized Medicine and Genetics, and is based in Potomac, Maryland, United States. jVen Capital is listed as a venture capital in the ConnectSafely investor database.

What stage does jVen Capital invest at?

jVen Capital backs companies at Seed, Early Stage and Growth.

Which regions does jVen Capital invest in?

jVen Capital invests across United States.

What companies has jVen Capital invested in?

jVen Capital's portfolio includes Foundation Medicine, Veracyte, Sunwink, GeneWerk Holdings GmbH, Kyverna Therapeutics, Fluidigm, Assurex Health and CAS Medical Systems.

Last updated · Source: ConnectSafely investor database